BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 10583575)

  • 1. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.
    Burjonrappa SC; Reddimasu S; Nawaz Z; Gao X; Sharma P; Loggie B
    Indian J Cancer; 2007; 44(1):1-5. PubMed ID: 17401217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.
    Arul GS; Moorghen M; Myerscough N; Alderson DA; Spicer RD; Corfield AP
    Gut; 2000 Dec; 47(6):753-61. PubMed ID: 11076872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
    Guillem P; Billeret V; Buisine MP; Flejou JF; Lecomte-Houcke M; Degand P; Aubert JP; Triboulet JP; Porchet N
    Int J Cancer; 2000 Dec; 88(6):856-61. PubMed ID: 11093805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of sulfated carbohydrate chain and core peptides of mucin detected by monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma.
    Endo T; Tamaki K; Arimura Y; Itoh F; Hinoda Y; Hareyama M; Irimura T; Fujita M; Imai K
    J Gastroenterol; 1998 Dec; 33(6):811-5. PubMed ID: 9853552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
    Ozcan HEA; Anuk T; Ozden O
    Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2.
    Van De Bovenkamp JH; Korteland-Van Male AM; Warson C; Büller HA; Einerhand AW; Ectors NL; Dekker J
    Histopathology; 2003 Jun; 42(6):555-65. PubMed ID: 12786891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic differences between esophageal and gastric intestinal metaplasia.
    Piazuelo MB; Haque S; Delgado A; Du JX; Rodriguez F; Correa P
    Mod Pathol; 2004 Jan; 17(1):62-74. PubMed ID: 14631367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus.
    Labouvie C; Machado JC; Carneiro F; Sarbia M; Vieth M; Porschen R; Seitz G; Blin N
    J Cancer Res Clin Oncol; 1999; 125(2):71-6. PubMed ID: 10190312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
    World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
    Phillips RW; Frierson HF; Moskaluk CA
    Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.
    Bax DA; Haringsma J; Einerhand AW; van Dekken H; Blok P; Siersema PD; Kuipers EJ; Kusters JG
    J Clin Pathol; 2004 Dec; 57(12):1267-72. PubMed ID: 15563666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time gated fluorescence spectroscopy in Barrett's oesophagus.
    Ortner MA; Ebert B; Hein E; Zumbusch K; Nolte D; Sukowski U; Weber-Eibel J; Fleige B; Dietel M; Stolte M; Oberhuber G; Porschen R; Klump B; Hörtnagl H; Lochs H; Rinneberg H
    Gut; 2003 Jan; 52(1):28-33. PubMed ID: 12477755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett's esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett's esophagus.
    Gulmann C; Shaqaqi OA; Grace A; Leader M; Patchett S; Butler D; Kay E
    Appl Immunohistochem Mol Morphol; 2004 Jun; 12(2):142-7. PubMed ID: 15354740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
    Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
    Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma.
    Piessen G; Wacrenier A; Briez N; Triboulet JP; Van Seuningen I; Mariette C
    J Clin Pathol; 2009 Dec; 62(12):1144-6. PubMed ID: 19946103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.